Cite
Specific induction of CD33 expression by E2A–HLF: the first evidence for aberrant myeloid antigen expression in ALL by a fusion transcription factor.
MLA
Akahane, K., et al. “Specific Induction of CD33 Expression by E2A–HLF: The First Evidence for Aberrant Myeloid Antigen Expression in ALL by a Fusion Transcription Factor.” Leukemia (08876924), vol. 24, no. 4, Apr. 2010, pp. 865–69. EBSCOhost, https://doi.org/10.1038/leu.2010.8.
APA
Akahane, K., Inukai, T., Inaba, T., Kurosawa, H., Look, A. T., Kiyokawa, N., Fujimoto, J., Goto, H., Endo, M., Zhang, X., Hirose, K., Kuroda, I., Honna, H., Kagami, K., Goi, K., Nakazawa, S., & Sugita, K. (2010). Specific induction of CD33 expression by E2A–HLF: the first evidence for aberrant myeloid antigen expression in ALL by a fusion transcription factor. Leukemia (08876924), 24(4), 865–869. https://doi.org/10.1038/leu.2010.8
Chicago
Akahane, K., T. Inukai, T. Inaba, H. Kurosawa, A. T. Look, N. Kiyokawa, J. Fujimoto, et al. 2010. “Specific Induction of CD33 Expression by E2A–HLF: The First Evidence for Aberrant Myeloid Antigen Expression in ALL by a Fusion Transcription Factor.” Leukemia (08876924) 24 (4): 865–69. doi:10.1038/leu.2010.8.